14.80
price down icon0.47%   -0.07
after-market Handel nachbörslich: 14.78 -0.02 -0.14%
loading

Finanzdaten der 89 Bio Inc-Aktie (ETNB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
52.58%
115.82
75.91 151.94 53.44 57.28
Interest Income/Expense
10.26%
1.137
1.267 2.362 0.874 0.863
Operating Income/Loss
52.58%
-115.82
-75.91 -151.94 -53.44 -57.28
Income/Loss From Continuing Operations Before Tax
55.68%
-110.75
-71.14 -148.87 -47.84 -51.58
Income Tax Expense/Benefit
449.64%
0.753
0.137 0.204 0.134 0.097
Income/Loss From Continuing Operations After Tax
56.44%
-111.50
-71.28 -149.07 -47.97 -51.68
Net Income/Loss
56.44%
-111.50
-71.28 -149.07 -47.97 -51.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7.87%
157.88
146.37 107.08 99.83 95.85
Diluted Average Shares
7.87%
157.88
146.37 107.08 99.83 95.85
Basic Earnings Per Share
44.90%
-0.71
-0.49 -1.39 -0.48 -0.54
Diluted Earnings Per Share
44.90%
-0.71
-0.49 -1.39 -0.48 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):